Non-clinical studies in support of IND/NDA/BLA submissions
Active Awarded Last action
- Contract number
- 75N93022F00001
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,179,640
Award facts
- Contract value 100% obligated
- $6,179,640.00 Current and potential, with all options
- Completion date 85% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Change Order | $2,133,733 | |
| Change Order | $1,928,640 | |
| Original award | $2,117,267 |
About this award
This is a $6,179,640.00 Cost Plus Fixed Fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to SRI International, a non-profit research and development institute. The contract is for non-clinical studies in support of Investigational New Drug (IND), New Drug Application (NDA), and Biologics License Application (BLA) submissions. It has an ultimate completion date of July 20, 2027 and was awarded on September 1, 2022. The contract does not have a set-aside designation. SRI International has been awarded other federal contracts and grants, demonstrating its extensive capabilities across scientific and engineering domains. The contract includes two subcontracts, one for clinical studies and one for a pharmacokinetic (PK) study, awarded to Charles River Laboratories, a global contract research organization.
Quick answers
Who was awarded contract 75N93022F00001?
75N93022F00001 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2022.
How much is contract 75N93022F00001 worth?
The government has obligated $6,179,640 on 75N93022F00001.
Is contract 75N93022F00001 an order under another contract?
Yes. 75N93022F00001 is a delivery order under 75N93020D00011, an indefinite delivery contract.
Was contract 75N93022F00001 competed?
The extent of competition for 75N93022F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award